Huaizhu Guo

Huaizhu Guo

Auto-generated profile, based on publicly available information

Huaizhu Guo

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Digestive and Liver Disease
Verified
Journal Article
Open access
SLSiqi Lu
Siqi Lu
YCYuzhu Chen
Yuzhu Chen
HGHuaizhu Guo
Huaizhu Guo
ZLZuojing Liu
Zuojing Liu
YDYanlin Du
Yanlin Du
LDLiping Duan
Liping Duan
Irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) share similar abdominal symptoms; however, their differentiation remains controversial. To illustrate the differences between the two conditions. Patients and healthy controls completed questionnaires and provided stool samples for analysis. IBS presented with the most severe symptoms and was specifically characterized by intense abdominal pain and frequent episodes of diarrhea. Patients with IBS displayed more dysregulated taxonomy within the fecal microbiota than SIBO. Opportunistic pathogens, including Lachnoclostridium, Escherichia-Shigella, and Enterobacter were enriched in the IBS group which contributed to increased bacterial pathogenicity and positively correlated with abdominal pain and bloating, meanwhile, Lachnoclostridium and Escherichia-Shigella were found to be associated with metabolites affiliated to bile acids, alcohols and derivatives. Bacteria enriched in SIBO group correlated with constipation. The bacterial co-occurrence network within the SIBO group was the most intricate. Ruminococcaceae Group were defined as core bacteria in SIBO. Differential metabolites affiliated to androstane steroids and phenylacetic acids were associated with core bacteria. Our study elucidates the differences between IBS and SIBO in terms of symptoms, microbiota and functions, which provides insights into a better understanding of both diseases and evidence for different treatment strategies.